
Oncologist

No OPD information available
Bone Tumor
Brain Tumor
Melanoma
Acoustic Neuroma
Adenoid Cystic Carcinoma
Astrocytoma
Cerebral Cavernous Malformation
Ear Cancer
Fractured Spine
Gamma Knife Radiosurgery
Gestational Trophoblastic Disease
Glioblastoma
Glioma
Gliomatosis Cerebri
Head and Neck Squamous Cell Carcinoma (HNSCC)
Lung Cancer
Lung Metastases
Lymphadenectomy
Meningioma
Merkel Cell Carcinoma
Neuroendocrine Tumor
Neurofibromatosis Type 2 (NF2)
Non-Small Cell Lung Cancer (NSCLC)
Renal Cell Carcinoma (RCC)
Salivary Gland Tumors
Schwannoma
Schwannomatosis
Spinal Tumor
Trophoblastic Tumor Placental Site
Matthew C. Foote is a doctor who helps patients with different types of tumors like bone, brain, and melanoma. He also treats conditions like ear cancer, lung cancer, and spinal tumors. Some of the special skills and treatments he uses include Gamma Knife Radiosurgery and lymphadenectomy.
Dr. Foote talks to his patients in a friendly and clear way, making sure they understand their treatment options. Patients trust him because he listens to their concerns and explains things well. He stays updated with the latest medical knowledge by reading research papers and attending conferences.
Dr. Foote works well with other medical professionals, sharing his knowledge and collaborating on patient care. His colleagues appreciate his expertise and dedication to helping patients. Dr. Foote's work has positively impacted many patients' lives by providing effective treatments and improving their health outcomes.
One of Dr. Foote's notable publications is about the role of imaging in spine radiotherapy, showing his expertise in this area. He has also led clinical trials to evaluate new treatments for melanoma, showing his commitment to advancing medical research.
In summary, Dr. Matthew C. Foote is a skilled and caring doctor who specializes in treating various tumors and cancers. He communicates well with patients, stays updated with the latest medical knowledge, and collaborates effectively with other medical professionals. His work has made a positive impact on many patients' lives, and he continues to contribute to medical research through publications and clinical trials.
Enrollment Status: Completed
Published: November 27, 2024
Intervention Type: Radiation, Drug
Study Drug: Dabrafenib and Trametinib (Combination)
Study Phase: Phase 1/Phase 2
